Septocaine

Septocaine is a brand name of articaine/epinephrine, approved by the FDA in the following formulation(s):

SEPTOCAINE (articaine hydrochloride; epinephrine bitartrate - injectable; injection)

• 
  Manufacturer: DEPROCO
  
  Approval date: April 3, 2000
  
  Strength(s): 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML) ^[RLD][AP]


• 
  Manufacturer: DEPROCO
  
  Approval date: March 30, 2006
  
  Strength(s): 4%;EQ 0.0085MG BASE/1.7ML (4%;EQ 0.005MG BASE/ML) ^[RLD]

Has a generic version of Septocaine been approved?

Yes. The following products are equivalent to Septocaine:

ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE (articaine hydrochloride; epinephrine bitartrate injectable; injection)

• 
  Manufacturer: HOSPIRA
  
  Approval date: June 18, 2010
  
  Strength(s): 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML) ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Septocaine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Septocaine.

See also...

• Septocaine Consumer Information (Cerner Multum)
• Septocaine AHFS DI Monographs (ASHP)
• Articaine and epinephrine Consumer Information (Cerner Multum)
• Articaine Hydrochloride AHFS DI Monographs (ASHP)